{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:13:50Z","timestamp":1769573630543,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01EB021708"],"award-info":[{"award-number":["1R01EB021708"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10RR023452-01"],"award-info":[{"award-number":["1S10RR023452-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD025234-01"],"award-info":[{"award-number":["1S10OD025234-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD018035"],"award-info":[{"award-number":["S10OD018035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB022544"],"award-info":[{"award-number":["P41EB022544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS100164"],"award-info":[{"award-number":["1R01NS100164"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11307-021-01586-0","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T22:52:05Z","timestamp":1612911125000},"page":"527-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Synthesis and Characterization of [18F]JNJ-46356479 as the First 18F-Labeled PET Imaging Ligand for Metabotropic Glutamate Receptor 2"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4817-0052","authenticated-orcid":false,"given":"Gengyang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas J.","family":"Guehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hyun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeva","family":"Dhaynaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Shoup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoda","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"El Fakhri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc D.","family":"Normandin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3814-868X","authenticated-orcid":false,"given":"Anna-Liisa","family":"Brownell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"1586_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0896-6273(92)90118-W","volume":"8","author":"Y Tanabe","year":"1992","unstructured":"Tanabe Y, Masu M, Ishii T, Shigemoto R, Nakanishi S (1992) A family of metabotropic glutamate receptors. Neuron 8:169\u2013179","journal-title":"Neuron"},{"key":"1586_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","volume":"75","author":"J Cartmell","year":"2000","unstructured":"Cartmell J, Schoepp DD (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75:889\u2013907","journal-title":"J Neurochem"},{"key":"1586_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejphar.2009.12.041","volume":"639","author":"S Chaki","year":"2010","unstructured":"Chaki S (2010) Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia. Eur J Pharmacol 639:59\u201366","journal-title":"Eur J Pharmacol"},{"key":"1586_CR4","doi-asserted-by":"crossref","unstructured":"Downing AM, Kinon BJ, Millen BA Zhang L, Liu L, Morozova MA, Brenner B, Rayle TJ, Nisenbaum L, Zhao F, Gomez JC (2014) A double-bind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia. BMC Psychiatry 14:351","DOI":"10.1186\/s12888-014-0351-3"},{"key":"1586_CR5","doi-asserted-by":"crossref","unstructured":"Feyissa AM, Woolverton WL, Miguel-Hidalgo JJ, Wang Z, Kyle PB, Hasler G, Stockmeier CA, Iyo AH, Karolewicz B (2010) Elevated level of metabotropic glutamate receptor 2\/3 in the prefrontal cortex in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 34:279\u2013283","DOI":"10.1016\/j.pnpbp.2009.11.018"},{"key":"1586_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/npp.2008.156","volume":"34","author":"PJ Conn","year":"2009","unstructured":"Conn PJ, Jones CK (2009) Promise of mGluR2\/3 activators in psychiatry. Neuropsychopharmacol 34:248\u2013249","journal-title":"Neuropsychopharmacol"},{"key":"1586_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fphar.2016.00130","volume":"7","author":"C Muguruza","year":"2016","unstructured":"Muguruza C, Meana JJ, Callado LF (2016) Group II metabotropic glutamate receptors as targets for novel antipsychotic drugs. Front Pharmacol 7:130","journal-title":"Front Pharmacol"},{"key":"1586_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fnmol.2018.00383","volume":"11","author":"M Mazzitelli","year":"2018","unstructured":"Mazzitelli M, Palazzo E, Maione S, Neugebauer V (2018) Group II Metabotropic Glutamate receptors: role in pain mechanisms and pain modulation. Front Mol Neurosci 11:383","journal-title":"Front Mol Neurosci"},{"key":"1586_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.brainres.2010.09.072","volume":"1363","author":"G Richards","year":"2010","unstructured":"Richards G, Messer J, Faull RLM, Stadler H, Wichmann J, Huguenin P, Bohrmann B, Mutel V (2010) Altered distribution of mGlu2 receptors in \u03b2-amyloid-affected brain regions of Alzheimer cases and aged PS2APP mice. Brain Res 1363:180\u2013190","journal-title":"Brain Res"},{"key":"1586_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1124\/mol.110.067488","volume":"79","author":"F Caraci","year":"2011","unstructured":"Caraci F, Molinaro G, Battaglia G et al (2011) Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies \u03b2-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective. Mol Pharmacol 79:618\u2013626","journal-title":"Mol Pharmacol"},{"key":"1586_CR11","doi-asserted-by":"crossref","unstructured":"Leurquin-Sterk G, Celen S, Van Laere K, Koole M, Bormans G, Langlois X , Van Hecken A, Te Riele P, Alc\u00e1zar J, Verbruggen A, de Hoon J, Andr\u00e9s J-I, Schmidt ME (2017) What we observe in vivo is not always what we see in vitro: development and validation of 11C-JNJ-42491293, A novel radioligand for mGluR2. J Nucl Med 58:110\u2013116","DOI":"10.2967\/jnumed.116.176628"},{"key":"1586_CR12","doi-asserted-by":"crossref","unstructured":"Andres JI, Alcazar J, Cid JM, De Angelis M, Iturrino L, Langlois X, Lavreysen H, Trabanco AA, Celen S, Bormans G (2012) Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging. J Med Chem 55:8685\u20138699","DOI":"10.1021\/jm300912k"},{"key":"1586_CR13","first-page":"213","volume":"57","author":"T Lohith","year":"2016","unstructured":"Lohith T, McQuade P, Salinas C et al (2016) First-in-human PET imaging of mGluR2 receptors. J Nucl Med 57:213","journal-title":"J Nucl Med"},{"key":"1586_CR14","first-page":"290","volume":"57","author":"P McQuade","year":"2016","unstructured":"McQuade P, Joshi A, Miller P et al (2016) Discovery and preclinical evaluation of an mGluR2-NAM PET radioligand. J Nucl Med 57:290","journal-title":"J Nucl Med"},{"key":"1586_CR15","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1021\/acschemneuro.7b00098","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Kumata K, Yamasaki T, Cheng R, Hatori A, Ma L, Zhang Y, Xie L, Wang L, Kang HJ, Sheffler DJ, Cosford NDP, Zhang MR, Liang SH (2017) Synthesis and preliminary studies of a novel negative allosteric modulator, 7-((2,5-dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[11C]methoxyphenyl)quinoline-2-carboxamide, for imaging of metabotropic glutamate receptor 2. ACS Chem Neurosci 8:1937\u20131948","journal-title":"ACS Chem Neurosci"},{"key":"1586_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bmc.2018.12.025","volume":"27","author":"K Kumata","year":"2019","unstructured":"Kumata K, Hatori A, Yamasaki T, Zhang Y, Mori W, Fujinaga M, Xie L, Nengaki N, Zhang MR (2019) Synthesis and evaluation of 4-(2-fluoro-4-[11C]methoxyphenyl)-5-((2-methylpyridin-4-yl)methoxy)picolinamide for PET imaging of the metabotropic glutamate receptor 2 in the rat brain. Bioorg Med Chem 27:483\u2013491","journal-title":"Bioorg Med Chem"},{"key":"1586_CR17","doi-asserted-by":"publisher","first-page":"11178","DOI":"10.7150\/thno.42587","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang Y, Chen Z, Shao T, van R, Kumata K, Deng X, Fu H, Yamasaki T, Rong J, Hu K, Hatori A, Xie L, Yu Q, Ye W, Xu H, Sheffler DJ, Cosford NDP, Shao Y, Tang P, Wang L, Zhang MR, Liang SH (2020) Synthesis and preliminary studies of 11C-labeled tetrahydro-1,7-naphthyridine-2-carboxamides for PET imaging of metabotropic glutamate receptor 2. Theranostics 10:11178\u201311196","journal-title":"Theranostics"},{"key":"1586_CR18","unstructured":"Li Z, Krause S, Suzuki M, Sasaki T (2016) Radiotracer compounds. World patent WO 2016\/033190 A1. 2016 Mar 3"},{"key":"1586_CR19","unstructured":"Van Gool MLM, Andres-Gil JI, Alcazar-Vaca MJ, Bormans GMR, Celen SJL, Joost V (2016) Radiolabelled mGluR2 PET ligands. World patent WO2016\/087489 A1"},{"key":"1586_CR20","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0024-3205(03)00482-X","volume":"73","author":"M Yu","year":"2003","unstructured":"Yu M, Nagren K, Chen YI et al (2003) Radiolabeling and biodistribution of methyl 2-(methoxycarbonyl)-2-(methylamino) bicyclo [2.1.1]-hexane-5-carboxylate, a potent neuroprotective drug. Life Sci 73:1577\u20131585","journal-title":"Life Sci"},{"key":"1586_CR21","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.bmcl.2012.01.039","volume":"22","author":"J-Q Wang","year":"2012","unstructured":"Wang J-Q, Zhang Z, Kuruppu D, Brownell AL (2012) Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate receptors in vivo. Bioorg Med Chem Lett 22:1958\u20131962","journal-title":"Bioorg Med Chem Lett"},{"key":"1586_CR22","doi-asserted-by":"publisher","first-page":"12060","DOI":"10.1021\/acs.jmedchem.0c01394","volume":"63","author":"G Yuan","year":"2020","unstructured":"Yuan G, Qu X, Zheng B, Neelamegam R, Afshar S, Iyengar S, Pan C, Wang J, Kang HJ, Ondrechen MJ, Poutiainen P, el Fakhri G, Zhang Z, Brownell AL (2020) Design, synthesis, and characterization of benzimidazole derivatives as positron emission tomography imaging ligands for metabotropic glutamate receptor 2. J Med Chem 63:12060\u201312072","journal-title":"J Med Chem"},{"key":"1586_CR23","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1021\/acs.jmedchem.6b00913","volume":"59","author":"JM Cid","year":"2016","unstructured":"Cid JM, Tresadern G, Vega JA, de Lucas AI, del Cerro A, Matesanz E, Linares ML, Garc\u00eda A, Iturrino L, P\u00e9rez-Benito L, Macdonald GJ, Oehlrich D, Lavreysen H, Peeters L, Ceusters M, Ahnaou A, Drinkenburg W, Mackie C, Somers M, Trabanco AA (2016) Discovery of 8-trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a selective and orally bioavailable mGlu2 receptor positive allosteric modulator (PAM). J Med Chem 59:8495\u20138507","journal-title":"J Med Chem"},{"key":"1586_CR24","doi-asserted-by":"publisher","first-page":"25223","DOI":"10.1039\/D0RA04943C","volume":"10","author":"G Yuan","year":"2020","unstructured":"Yuan G, Shoup TM, Moon SH, Brownell AL (2020) A concise method for fully automated radiosyntheses of [18F]JNJ-46356479 and [18F]FITM via Cu-mediated 18F-fluorination of organoboranes. RSC Adv 10:25223\u201325227","journal-title":"RSC Adv"},{"key":"1586_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0969-8051(00)00125-6","volume":"27","author":"J Hilton","year":"2000","unstructured":"Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF (2000) Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol 27:627\u2013630","journal-title":"Nucl Med Biol"},{"key":"1586_CR26","first-page":"1133","volume":"54","author":"T Collier","year":"2013","unstructured":"Collier T, Normandin M, El Fakhri G et al (2013) Automation of column-switching HPLC for analysis of radiopharmaceuticals and their metabolites in plasma. J Nucl Med 54:1133","journal-title":"J Nucl Med"},{"key":"1586_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE et al (2012) Fsl. Neuroimage 62:782\u2013790","journal-title":"Neuroimage"},{"key":"1586_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuroimage.2017.04.063","volume":"170","author":"J Seidlitz","year":"2018","unstructured":"Seidlitz J, Sponheim C, Glen D, Ye FQ, Saleem KS, Leopold DA, Ungerleider L, Messinger A (2018) A population MRI brain template and analysis tools for the macaque. Neuroimage 170:121\u2013131","journal-title":"Neuroimage"},{"key":"1586_CR29","volume-title":"The rhesus monkey brain in stereotaxic coordinates","author":"G Paxinos","year":"1999","unstructured":"Paxinos G, Huang XF, Toga AW (1999) The rhesus monkey brain in stereotaxic coordinates. Academic Press, San Diego"},{"key":"1586_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuroimage.2008.10.058","volume":"45","author":"DG McLaren","year":"2009","unstructured":"McLaren DG, Kosmatka KJ, Oakes TR et al (2009) A population-average MRI-based atlas collection of the rhesus macaque. Neuroimage 45:52\u201359","journal-title":"Neuroimage"},{"key":"1586_CR31","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533\u20131539","journal-title":"J Cereb Blood Flow Metab"},{"key":"1586_CR32","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1002\/chem.201604633","volume":"23","author":"J Zischler","year":"2017","unstructured":"Zischler J, Kolks N, Modemann D, Neumaier B, Zlatopolskiy BD (2017) Alcohol-enhanced Cu-mediated radiofluorination. Chem-Eur J 23:3251\u20133256","journal-title":"Chem-Eur J"},{"key":"1586_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0168-0102(97)00120-X","volume":"30","author":"H Ohishi","year":"1998","unstructured":"Ohishi H, Neki A, Mizuno N (1998) Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody. Neurosci Res 30:65\u201382","journal-title":"Neurosci Res"},{"key":"1586_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1124\/mol.117.110114","volume":"93","author":"DE O'Brien","year":"2018","unstructured":"O'Brien DE, Shaw DM, Cho HP et al (2018) Differential pharmacology and binding of mGlu2 receptor allosteric modulators. Mol Pharmacol 93:526\u2013540","journal-title":"Mol Pharmacol"},{"key":"1586_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/bph.13390","volume":"173","author":"ML Doornbos","year":"2016","unstructured":"Doornbos ML, Perez-Benito L, Tresadern G et al (2016) Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222. Br J Pharmacol 173:588\u2013600","journal-title":"Br J Pharmacol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-021-01586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-021-01586-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-021-01586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T15:29:58Z","timestamp":1626190198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-021-01586-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1586"],"URL":"https:\/\/doi.org\/10.1007\/s11307-021-01586-0","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"26 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved and done under the guidelines of the Subcommittee on Research Animals of the Massachusetts General Hospital and Harvard Medical School in accordance with the Guide of NIH for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}